Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-γ-producing CD56bright cells in tuberculous pleurisy

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6852-6860

  Schierloh, Pablo ^a   Yokobori, Noemi ^a   Alemán, Mercedes ^a   Musella, Rosa M ^a   Beigier Bompadre, Macarena ^a   Saab, María A ^a   Alves, Leandro ^a   Abbate, Eduardo ^a   De La Barrera, Silvia S ^a   Sasiain, María C ^a,b  

^a HOSPITAL F J MUÑIZ   (Argentina)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; L SELECTIN; LYMPHOCYTE MEMBRANE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; PERFORIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; PHENOTYPE; PLEURA BIOPSY; PLEURA FLUID; PRIORITY JOURNAL; THORACOCENTESIS; TUBERCULOUS PLEURISY;

EID: 27744560408     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6852     Document Type: Article

References (51)

1. Ellner, J., P. Barnes, R. Wallis, and R. Modlin. 1988. The immunology of tuberculous pleurisy. Semin. Respir. Infect. 3: 335-342.
2. Alemán, M., S. de la Barrera, P. Schierloh, L. Alves, N. Yokobori, M. Baldini, E. Abbate, and M. C. Sasiain. 2005. In tuberculous pleural effusions activated neutrophils undergo apoptosis and acquire dendritic cell-like phenotype. J. Infect. Dis. 192: 399-409.
3. Light, R., M. MacGregor, P. Luschsinger, and W. Ball. 1972. Pleural effusions: the diagnostic separations of transudates and exudates. Ann. Intern. Med. 72: 507-513.
4. Ashitani, J., H. Mukae, T. Hiratsuka, M. Nakazato, K. Kumamoto, and S. Matsukura. 2002. Elevated levels of α-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121: 519-526.
5. Zhang, M., M. Gately, E. Wang, J. Gong, S. Wolf, S. Lu, R. Modlin, and P. Barnes. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 93: 1733-1739.
6. Campbell, J. J., S. Qin, D. Unutmaz, D. Soler, K. E. Murphy, M. R. Hodge, L. Wu, E. C. Butcher, and A. J. Wardlaw. 2001. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J. Immunol. 166: 2842-2848.
7. Esin, S., G. Batoni, M. Pardini, F. Favilli, D. Bottai, G. Maisetta, W. Florio, R. Vanacore, H. Wigzell, and M. Campa. 2004. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guerin. Immunology 112: 143-152.
8. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor derived γδ T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96: 6879-6884.
9. Brill, K., Q. Li, R. Larkin, D. H. Canaday, D. R. Kaplan, W. H. Boom, and R. F. Silver. 2001. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect. Immun. 69: 1755-1765.
10. Fehniger, T. A., M. H. Shah, M. J. Turner, J. B. VanDeusen, S. P. Whitman, M. A. Cooper, K. Suzuki, M. Wechser, F. Goodsajd, and M. A. Caligiuri. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162: 4511-4520.
11. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640.
12. McQueen, K. L., and P. Parham. 2002. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14: 615-621.
13. Lanier, L. L. 2003. Natural killer cell receptor signaling. Curr. Opin. Immunol. 15: 308-314.
14. Borrego, F., M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks. 1998. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187: 813-818.
15. Borrego, F., J. Kabat, D. Kim, L. Lieto, K. Maasho, J. Peña, R. Solana, and J. E. Coligan. 2001. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol. Immunol. 38: 637-660.
16. de la Barrera, S., M. Finiasz, S. Fink, J. Ilarregui, M. Aleman, L. Olivares, M. C. Franco, G. Pizzariello, and M. C. Sasiain. 2004. NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13. Clin. Exp. Immunol. 135: 105-113.
17. Snyder, M. R., C. M. Weyand, and J. J. Goronzy. 2004. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol. 25: 25-32.
18. Schmidt, K. N., B. Leung, M. Kwong, K. A. Zaramber, S. Satyal, T. A. Navas, F. Wang, and P. J. Godowsky. 2004. APC-independent activation of NK cells by Toll-like receptor 3 agonist double-stranded RNA. J. Immunol. 172: 138-143.
19. Chalifour, A., P. Jeannin, J. Gauchat, A. Blaecke, M. Malissard, T. N'Guyen, N. Thleblemont, and Y. Delneste. 2004. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production. Blood 104: 1778-1783.
20. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166: 6477-6482.
21. dim natural killer cell subsets. J. Immunol. 161: 400-408.
22. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
23. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowing, G. Bougras, W. A. Muller, L. Moretta, and C. Münz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101: 16606-16611.
24. Ferlazzo, G., D. Thomas, S. L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and C. Münz. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172: 1455-1462.
25. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173: 6418-6426.
26. dim NK cells. Eur. J. Immunol. 31: 3121-3126.
27. bright subset. Blood 97: 3146-3151.
28. Cooper, M. A., T. A. Fehniger, A. Fuchs, M. Colonna, and M. A. Caligiuri. 2004. NK cell and DC interactions. Trends Immunol. 25: 47-52.
29. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Münz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-350.
30. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333,
31. bright natural killer cell subset: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur. J. Immunol. 27: 354-360.
32. Loza, M. J., L. Zamai, L. Azzoni, E. Rossati, and B. Perussia. 2002. Expression of type 1 (IFN-γ) and type 2 (IL-13, IL-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 99: 1273-1281.
33. high stage and effector functions. J. Immunol. 172: 88-96.
34. Koopman, L. A., H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, et al. 2003. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198: 1201-1212.
35. Hanna, J., P. Bechtel, Y. Zhai, F. Youssef, K. McLachlam, and O. Mandelboim. 2004. Novel insights on human NK cell's immunological modalities reveled by gene expression profiling. J. Immunol. 173: 6547-6563.
36. Kaufmann, S. H. E. 2001. How can immunology contribute to the control of tuberculosis? Nat Rev. 1: 20-30.
37. Das, H., V. Groh, C. Kuijl, M. Sugita, C. T. Morita, T. Spies, and J. F. Bukowski. 2001. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 5: 83-93.
38. Martín-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavechia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-γ for Th1 priming. Nat. Immunol. 5: 1260-1265.
39. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity, impact on the adaptive immune response. Curr. Opin. Immunol. 9: 4-9.
40. Hiraki, A., K. Matsuo, K. Murakami, T. Murakami, T. Onoda, K. Sugi, H. Takeyama and R. Eda. 2003. Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion. Int. J. Tuberc. Lung Dis. 7: 1172-1177.
41. Yamada, Y., A. Nakamura, M. Hosoda, T. Kato, T. Asano, K. Tonegawa, and M. Itoh. 2001. Cytokines in pleural liquid for diagnosis of tuberculous pleurisy. Respir. Med. 95: 577-581.
42. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. Stewart, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
43. + T cell effector function in response to an intracellular pathogen. J. Immunol. 172: 130-137.
44. Ortaldo, J., A. Mason, and J. O'Shea. 1995. Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med. 181: 339-344.
45. Azzoni, L., I. Anegon, B. Calabretta, and B. Perussia. 1995. Ligand binding to FcyR induces c-myc-dependent apoptosis in IL-2 stimulated NK cells. J. Immunol. 154: 491-499.
46. Hirsh, C., Z. Toossi, J. Johnson, H. Luzze, L. Ntambi, P. Peters, M. McHugh, A. Okwera, M. Joloba, P. Mugyenyi, et al. 2001. Augmentation of apoptosis and interferon-γ production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J. Infect. Dis. 183: 779-788.
47. Spaggiari, G., P. Contini, A. Dondero, R. Carosio, F. Puppo, F. Indiveri, M. Zocchi, and A. Poggi. 2002. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer activating HLA class I receptors through FasL-Fas interaction. Blood 100: 4098-4107.
48. Kashii, Y., R. Giorda, R. Herberman, T. Whiteside, and N. Vujanovic. 1999. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J. Immunol. 163: 5358-5366.
49. Gunturi, A., R. E. Berg, and J. Forman. 2003. Preferential survival of CD8 T and NK cell expressing high levels of CD94. J. Immunol. 170: 1737-1745.
50. Lande, R., E. Giacomini, T. Grassi, M. E. Remoli, E. Iona, M. Miettinen, I. Julkunen, and E. M. Coccia. 2003. IFN-αβ released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J. Immunol. 170: 1174-1182.
51. Maghazachi, A. 2005. Compartmentalization of human natural killer cells. J. Mol. Immunol. 42: 523-529.